Literature DB >> 17237935

Colistin and rhabdomyolysis: a causative agent or an innocent bystander?

Penelope Evagelopoulou, Andreas Katsaros, Pavlos Myrianthefs, Stylianos Karatzas, Eleni Boutzouka, George Fildissis, George Baltopoulos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237935     DOI: 10.1007/s00134-006-0515-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  7 in total

1.  Colistin interactions with the mammalian urothelium.

Authors:  Jamie R Lewis; Simon A Lewis
Journal:  Am J Physiol Cell Physiol       Date:  2003-12-10       Impact factor: 4.249

Review 2.  Polymyxins: pharmacology, pharmacokinetics, pharmacodynamics, and clinical applications.

Authors:  Elizabeth D Hermsen; Christopher J Sullivan; John C Rotschafer
Journal:  Infect Dis Clin North Am       Date:  2003-09       Impact factor: 5.982

Review 3.  Oxygen delivery.

Authors:  S M Hameed; W C Aird; S M Cohn
Journal:  Crit Care Med       Date:  2003-12       Impact factor: 7.598

Review 4.  Pathogenesis and treatment of renal dysfunction in rhabdomyolysis.

Authors:  S G Holt; K P Moore
Journal:  Intensive Care Med       Date:  2001-05       Impact factor: 17.440

5.  Modulation of polymyxin B effects on mammalian urinary bladder.

Authors:  J R Berg; C M Spilker; S A Lewis
Journal:  Am J Physiol       Date:  1998-08

Review 6.  Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians.

Authors:  Ana L Huerta-Alardín; Joseph Varon; Paul E Marik
Journal:  Crit Care       Date:  2004-10-20       Impact factor: 9.097

Review 7.  Toxicity of polymyxins: a systematic review of the evidence from old and recent studies.

Authors:  Matthew E Falagas; Sofia K Kasiakou
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

  7 in total
  1 in total

1.  Polymyxin B-induced rhabdomyolysis: A case report.

Authors:  Ming Ni; Xiangdong Meng; Limin Wang; Yanan Zhao; Min Yu; Sheng Shi
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.